Form: EFFECT

Notice of Effectiveness

July 15, 2021

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 15, 2021
Accession Number:
Submission Type:
CIK: 0001444192
Company Name: Acasti Pharma Inc.
File Number: 333-257589